Similar articles

• Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg).

  Omata M, Afroudakis A, Liew CT, Ashcavai M, Peters RL. Omata M, et al. Gastroenterology. 1978 Dec;75(6):1003-9. Gastroenterology. 1978. PMID: 710851 No abstract available.
• [Significance of the presence of Australia antigen in liver diseases seen in a department of internal medicine in Abidjan].

  Soubeyrand J, Ticolat R, Leleu JP, Condat JM, Niamkey E, Diallo D, Manlan KL, Ouattara D, Beda BY. Soubeyrand J, et al. Sem Hop. 1982 Dec 16;58(46):2702-8. Sem Hop. 1982. PMID: 6297069 French.
• [Problem of chronic hepatitis (classification, pathogenesis and treatment].

  Podymova SD. Podymova SD. Klin Med (Mosk). 1991 Jun;69(6):9-13. Klin Med (Mosk). 1991. PMID: 1774926 Review. Russian.
• Role of serum hepatitis virus in chronic liver disease.

  Prince AM. Prince AM. Gastroenterology. 1971 May;60(5):913-21. Gastroenterology. 1971. PMID: 4931955 Review. No abstract available.
• Antibodies to liver cell membrane antigens in chronic active hepatitis (CAH). III. Partial characterization of the liver cell membrane antigens and comparison of reactivities in sera from patients with various liver diseases.

  Frazer IH, Mackay IR. Frazer IH, et al. Clin Exp Immunol. 1984 Aug;57(2):429-37. Clin Exp Immunol. 1984. PMID: 6432384 Free PMC article.